平特五不中

My current research program is translational in nature and seeks to identify genetic determinants of donor and recipient compatibility to inform strategies to prevent kidney transplant rejection. I am also interested in contributing to the appreciation of each patient鈥檚 status across a continuum of risk, which extends from rejection, on one side, and adverse effects of immunosuppressants (including: infection, malignancy, metabolic聽syndrome, and cardiovascular disease), on the other. Such initiatives are geared towards optimizing organ allocation schemes, developing clinically applicable instruments, guiding personalized surveillance schedules, and informing individually tailored therapies.